Adherex Technologies, Inc.

Adherex Technologies, Inc.

Sector: Pharmaceutical Preparations Region: NC, United States

: | Toronto Stock Exchange: AHX.WT | OTC Markets: ADHXF | Toronto Stock Exchange: AHX | OTC Markets: ADRXF

Similar to: Mast Therapeutics, Inc., BioAlliance Pharma SA, Sanofi

Adherex Technologies, Inc. is a clinical stage biotechnology company that develops Sodium Thiosulfate, a chemo-protectant against hearing loss associated with platinum-based chemotherapy. Its research and development efforts have been focused on the development of cancer therapeutics and its cadherin technology platform, which currently include eniluracil and Sodium Thiosulfate. Adherex Technologies was founded by Orest W. Blaschuk on September 3, 1996 and is headquartered in Durham, NC.

News & Analysis

You may also be interested in: